Form 8-K - Current report:
SEC Accession No. 0001213900-24-068589
Filing Date
2024-08-14
Accepted
2024-08-14 08:00:13
Documents
15
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211338-8k_cormed.htm   iXBRL 8-K 23436
2 PRESS RELEASE DATED AUGUST 14, 2024 ea021133801ex99-1_cormed.htm EX-99.1 54863
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5502
  Complete submission text file 0001213900-24-068589.txt   267919

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20240814.xsd EX-101.SCH 3015
5 XBRL LABEL FILE crmd-20240814_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20240814_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0211338-8k_cormed_htm.xml XML 3671
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 241204239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)